A detailed history of Lmr Partners LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Lmr Partners LLP holds 45,000 shares of LLY stock, worth $35.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
45,000
Previous 499 8918.04%
Holding current value
$35.8 Million
Previous $451,000 8739.69%
% of portfolio
0.37%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $2.91 Million - $3.62 Million
3,769 Added 755.31%
4,268 $3.78 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $3.58 Million - $4.48 Million
-4,932 Reduced 90.81%
499 $451,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $3.22 Million - $4.3 Million
5,431 New
5,431 $4.23 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $6.15 Million - $7.22 Million
-19,783 Reduced 40.34%
29,261 $10 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $15.8 Million - $18.4 Million
49,044 New
49,044 $17.9 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $5.35 Million - $6.64 Million
-23,789 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $4.97 Million - $6.12 Million
22,442 Added 1666.07%
23,789 $5.5 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $56,331 - $72,864
-312 Reduced 18.81%
1,347 $309,000
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $272,606 - $352,902
1,659 New
1,659 $310,000
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $4.51 Million - $5.22 Million
-30,867 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $4.21 Million - $5.07 Million
30,867 New
30,867 $5.07 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $1.22 Million - $1.51 Million
-11,381 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $2.23 Million - $2.43 Million
-20,901 Reduced 64.75%
11,381 $1.27 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $3.58 Million - $4.17 Million
32,282 New
32,282 $3.58 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $2.96 Million - $3.49 Million
-26,631 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $2.82 Million - $3.16 Million
26,631 New
26,631 $3.08 Million
Q4 2017

Jan 30, 2018

SELL
$81.94 - $87.89 $383,233 - $411,061
-4,677 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $360,456 - $400,070
4,677
4,677 $400,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.